Presentation title: Keynote presentation: Opportunities and challenges for microbiome engineering
Morten Sommer is Professor of Microbiology and Scientific Director at the Novo Nordisk Foundation Center for Biosustainability at the Technical University of Denmark (DTU). Morten Sommer received his MSc in physics from U Copenhagen and his PhD from Harvard University in Biophysics. Before starting his own lab Morten Sommer worked with professors George Church, Stephen Quake and Sine Larsen.
Morten Sommer now works on understanding and harnessing evolutionary processes and biological diversity. Genome and metagenome wide screens and perturbations are used in conjunction with synthetic biology tools to understand the evolution and phenotypic stability of biosynthetic processes, drug resistance and complex microbial communities.
Morten Sommer has started several companies, including UTILITY therapeutics (2018), SNIPR biome (2017), Clinical-Microbiomics (2015), Biosyntia (2012), UNION therapeutics (2013) and Microlytic (2006), which was acquired by Anatrace in 2014.